Skip to content
  • HOME
  • Technology
    • ARCEDI Technology
    • Patents
    • Publications
  • Products
    • ARCEDI Products
    • EVITA Test Complete
    • EVITA Test Gender
    • Pipeline
  • About
    • About ARCEDI
    • Executive management
    • Board of directors
    • Investor
  • Contact
  • NEWS
Menu
  • HOME
  • Technology
    • ARCEDI Technology
    • Patents
    • Publications
  • Products
    • ARCEDI Products
    • EVITA Test Complete
    • EVITA Test Gender
    • Pipeline
  • About
    • About ARCEDI
    • Executive management
    • Board of directors
    • Investor
  • Contact
  • NEWS
Search
Close

Press photos

  • -
  • April 6, 2021
  • Niewijk G.

Download press photos below

PrevPreviousCell-based non-invasive prenatal testing for monogenic disorders: confirmation of unaffected fetuses following preimplantation genetic testing
NextCase stories (in Danish): Vores oplevelse med EVITA TESTNext

ADDRESS

Main office 
Tabletvej 1 | DK-7100 Vejle | Denmark

Aarhus office
INCUBA | Palle Juul-Jensens Boulevard 82 |
DK-8200 Aarhus N | Denmark

CONTACT

If you have any questions regarding ARCEDI,
you are welcome to contact us

CVR NR.

CVR nr.: 25577922

Follow us

LinkedIn

If you are pregnant

ARCEDI’s prenatal tests can give you peace of mind concerning your future child. Learn more about EVITA TEST COMPLETE and EVITA TEST GENDER at evitatest.com

Go to EVITA TEST

©2021 ARCEDI Biotech ApS. All rights reserved. ARCEDI® is a registred trademark.

Empowered by design-people